Dhanyak jirakadi modak in vatrakta (Gout).

RANDOMISED OPEN CONTROLLED CLINICAL STUDY TO EVALUATE THE EFFICACY OF DHANYAK JIRAKADI MODAK IN VATRAKTA.

Status

Active, not recruiting

Phases

Phase 2Phase 3

Study type

Interventional

Source

CTRI

Registry ID

CTRI/2022/10/046250

Enrollment

Registered

2022-10-07

Start date

Unknown

Completion date

Unknown

Last updated

2022-10-17

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: M109- Gout, unspecified

Interventions

None listed

Eligibility

Inclusion criteria

Inclusion criteria: 1 Age group 18 to 60yrs 2 Irrespective of Gender 3 Patient presenting with clinical sign and symptoms specific with Toda and Sthabdhata in uttan vatrakta in relation to parva sadhi

Exclusion criteria

Exclusion criteria: 1 Known case of Amavata Sandhigatvata SLE 2 Patient on chronic use of NSAIDS and steroidal inflammatory drugs 3 Pregnancy 4 Patients prediagnosed with autoimmune disease of joint

Design outcomes

Primary

Measure	Time frame
Decrease in sign and symptoms of vatrakta.Timepoint: 30 days	—

Secondary

Measure	Time frame
Decrease in Uric acid level and Pain.Timepoint: 30 days	—

Countries

India

Contacts

Public ContactDr Palavee Mukesh Chaudhari

Yashwant Ayurved College PG Training Centre Kodoli

suryakiran_wagh@rediffmail.com9822846910

Outcome results